Blueprint Medicines Corporation

Blueprint Medicines Corporation is a biotechnology company that researches, develops, and commercializes pharmaceutical drugs. The standard development pathway for such therapeutics involves preclinical testing on animals to assess safety and efficacy prior to human clinical trials. This constitutes commercial exploitation of animals under the firm's exclusion policy.

The evidence gathered from corporate filings shows the company's operations are fundamentally structured around the "Exploitation" of licensed products, defined within its agreements as the research, development, manufacture, and commercialization of drug candidates. This business model inherently relies on animal testing. While the specific scale and nature of Blueprint's animal testing are not detailed in the provided evidence, the company's core activity as a drug developer places it within the scope of the animal exploitation exclusion.